0001255627-20-000002.txt : 20200910 0001255627-20-000002.hdr.sgml : 20200910 20200910173549 ACCESSION NUMBER: 0001255627-20-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200908 FILED AS OF DATE: 20200910 DATE AS OF CHANGE: 20200910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHREIBER DAVID CENTRAL INDEX KEY: 0001255627 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 201169397 MAIL ADDRESS: STREET 1: 15 TROTTERS LANE CITY: MONROE STATE: CT ZIP: 06468 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-09-08 0 0000926617 Aspira Women's Health Inc. AWH 0001255627 SCHREIBER DAVID C/O ASPIRA WOMEN'S HEALTH INC. 12117 BEE CAVES RD BLDG 3 STE 100 AUSTIN TX 78738 1 0 0 0 Common Stock 2020-09-08 4 S 0 50000 2.78 D 185018 D The proceeds are intended to cover tax liability for restricted stock units of Aspira Women's Health Inc. received in 2020. The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.75 to $2.85 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. /s/ David Schreiber 2020-09-10